ReLIA Biotech

ReLIA Biotech is a leading Chinese diagnostics and medical device company specializing in point-of-care testing technologies. The company has developed and commercialized several rapid diagnostic platforms, including multi-functional immunoassay systems and immunofluorescence detectors used to detect biomarkers relevant to cardiovascular, renal, and inflammatory diseases. Its products are certified by CFDA and ISO 13485 standards. The company's COVID‑19 IgG/IgM Antibody Assay Kit was recognized on the "white list" for export by China's Ministry of Commerce during the pandemic. ReLIA's clinical results are focused on accuracy, speed, and reliability of biomarker detection rather than therapeutic outcomes.